Skip to main content
. 2009 Jun 18;267(2):273–279. doi: 10.1007/s00405-009-1006-8

Table 2.

Metastatic RCC of head and neck region and their characteristics

Case # Mets Present Age at Dx Year at mets Survival (years) Tob.
1 Frontal lobe HA, LUE Numbness, weakness 24 4 17a
2 Cerebellum HAb, N/V, blurry vision 51 0 5 +
3 Frontal lobe, mandible, scalp Cystic lesions in the scalpb 55 0 1 +
4 Frontal lobe Frontal HA, memory loss 53 1 3
5 Frontal, occipital lobes, cerebellum Dizzinessb, dysarthria, dysphagia 58 0 1 +
6 Parotid Parotid mass 67 1 14a +
7 Eye c 55 11 14 +
8 Tongue Tongue cyst 27 0 1
9 Brain HA 62 0 <1 +
Case # Pathology Other mets Para-neoplastic syndromes Treatments
1 Poorly differentiated carcinoma, staining for GFAP Lung None Right frontal lobe craniotomy, nephrectomy, immune therapy, chemotherapy
2 Poorly differentiated (grade III), Bone marrow, liver None Nephrectomy, posterior fossa craniotomy, hepatic wedge resection, chemotherapy, XRT
3 c Adrenal, lungs, liver, skin Hypercalcemia IL-2, IFN a, XRT
4 Clear cell type (grade II) None Hypercalcemia Nephrectomy, craniotomy
5 Clear cell (not graded) Lungs Hypercalcemia XRT
6 Moderately well differentiated (grade II) Colon Polycythemia, hypercalcemia Nephrectomy, colectomy
7 c Bone None Nephrectomy, XRT, eye enucleation
8 Grade III Spine, lung, liver Hypercalcemia XRT, nephrectomy
9 Diagnosed by FNA Bone, lungs Hypercalcemia XRT

aStill alive

bCancer presented with mets

cInitial diagnosis and work up at another institution, further records not available